Figure 1From: uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer Celecoxib concentration predicts on biomarker change. In women taking celecoxib 400 mg bid, the change in PAI-1 (pg/mg) (A) and PGE2 (ng/mL) (B) in NAF and uPA (pg/mL) (C) in plasma correlated with celecoxib concentration (ng/mL).Back to article page